Skip to main content
. 2014 Dec 11;2:168. doi: 10.1186/s40478-014-0168-9

Table 2.

Expression levels of genes potentially regulating oligodendrocytes and their fold-changes in demyelinated inactive versus remyelinated lesions

Gene name CWM Remyelinated Demyelinated Active Re/CWM Re/De
Mean SEM Mean SEM Mean SEM Mean SEM Ratio p Ratio p
PDGFs
PDGFA 19.38 2.59 31.78 10.91 15.45 4.47 51.82 34.22 1.64 0.61 2.06 0.26
PDGFB 1.23 0.28 1.71 0.30 6.79 2.91 31.65 29.42 1.39 0.26 0.25 0.48
PDGFC 0.52 0.09 1.45 0.47 1.19 0.48 2.56 1.69 2.78 0.038 1.22 0.61
PDGFD 0.14 0.05 0.37 0.22 0.83 0.46 0.08 0.03 2.61 1.00 0.45 0.45
FGFs
FGF1 39.42 2.61 85.40 11.54 48.15 19.53 58.18 16.80 2.17 0.010 1.77 0.11
FGF2 3.82 0.56 9.23 0.88 10.25 2.62 6.08 0.63 2.41 0.010 0.90 0.91
FGF5 0.01 0.01 0.00 0.00 0.01 0.01 0.00 0.00 0.00* 0.15 0.00* 0.15
FGF8 0.00 0.00 0.06 0.05 0.02 0.01 0.01 0.00 16.25* 0.74 2.69* 0.72
FGF9 0.04 0.02 0.02 0.01 0.87 0.53 0.01 0.00 0.44* 0.71 0.02* 0.066
Semaphorins
SEMA3A 0.58 0.11 0.77 0.10 1.77 0.75 0.71 0.25 1.32 0.26 0.43 0.35
SEMA3B 6.33 1.73 10.48 4.21 2.82 1.50 5.37 3.57 1.66 0.61 3.72 0.11
SEMA3C 4.84 1.06 7.13 0.75 2.10 0.59 6.13 1.73 1.47 0.17 3.40 0.010
SEMA3D 0.55 0.09 2.18 0.57 1.08 0.37 0.85 0.23 3.94 0.019 2.02 0.11
SEMA3E 0.41 0.04 0.91 0.29 0.49 0.15 0.69 0.23 2.21 0.26 1.84 0.17
SEMA3F 0.02 0.01 0.02 0.01 0.20 0.10 1.91 1.89 0.93* 0.91 0.10* 0.44
SEMA3G 0.23 0.05 0.16 0.06 0.54 0.31 1.18 0.98 0.68 0.48 0.30 0.91
SEMA4A 0.22 0.06 0.21 0.05 1.00 0.36 0.29 0.04 0.95 0.91 0.21 0.067
SEMA4B 2.63 0.31 8.90 2.16 8.46 3.46 18.31 14.74 3.39 0.010 1.05 0.48
SEMA4C 4.49 0.77 8.07 2.81 3.67 0.83 9.90 6.17 1.80 0.26 2.20 0.11
SEMA4D 16.61 3.51 24.36 7.25 4.72 2.38 23.80 11.36 1.47 0.61 5.16 0.019
SEMA4F 0.40 0.04 1.27 0.13 3.09 0.67 4.83 4.19 3.18 0.010 0.41 0.11
SEMA4G 0.35 0.07 0.44 0.13 0.48 0.28 0.89 0.43 1.26 0.61 0.91 0.59
SEMA5A 2.38 0.56 3.06 0.45 3.08 1.07 8.98 7.60 1.28 0.61 0.99 0.91
SEMA5B 0.45 0.09 0.78 0.18 2.34 0.52 1.32 0.53 1.72 0.17 0.33 0.11
SEMA6A 28.24 6.78 45.65 12.14 12.75 3.45 31.24 4.13 1.62 0.26 3.58 0.010
SEMA6B 0.73 0.18 1.95 0.78 9.90 4.74 31.22 30.80 2.67 0.07 0.20 0.17
SEMA6C 0.05 0.01 0.07 0.03 0.13 0.06 0.06 0.02 1.53 0.28 0.54 0.83
SEMA6D 7.30 1.55 13.26 2.93 4.43 0.84 5.70 1.43 1.82 0.11 3.00 0.019
SEMA7A 2.85 0.75 3.91 0.35 0.93 0.50 2.99 1.56 1.37 0.48 4.22 0.019
Chemokines
CXCL1 0.18 0.07 1.18 0.32 4.46 3.25 1.30 1.04 6.51 0.019 0.27 0.76
CXCL2 0.17 0.08 0.62 0.14 1.10 0.47 3.49 2.96 3.70 0.019 0.56 0.91
CXCL8 0.23 0.06 0.51 0.19 0.71 0.15 0.52 0.42 2.22 0.26 0.71 0.61
CXCL10 0.02 0.01 0.05 0.02 0.04 0.03 0.88 0.47 1.94* 0.76 1.09 0.66
CXCL12 2.51 0.37 3.65 0.70 30.09 23.06 24.58 16.09 1.45 0.35 0.12 0.76
IL6 family
CNTF 0.19 0.04 0.52 0.11 0.20 0.11 0.69 0.50 2.66 0.019 2.65* 0.069
CLCF1 0.02 0.01 0.16 0.13 0.48 0.23 0.55 0.34 6.62* 0.35 0.34 0.83
CTF1 0.17 0.03 0.44 0.13 0.82 0.29 1.66 1.36 2.59 0.17 0.54 0.61
IL6 0.06 0.02 0.07 0.03 0.38 0.31 0.06 0.02 1.27 0.76 0.19 0.83
IL11 0.01 0.00 0.07 0.05 0.04 0.03 0.02 0.01 5.11* 1.00 1.63 0.91
LIF 0.01 0.00 0.03 0.02 0.76 0.70 0.43 0.37 5.17* 0.40 0.04 1
IGFs
IGF1 0.35 0.10 0.32 0.12 0.63 0.23 1.46 0.98 0.94 1.00 0.51 0.61
IGF2 0.23 0.01 0.33 0.12 6.04 4.62 1.95 1.23 1.42 0.26 0.06 0.39
Miscellaneous
CTGF 1.70 0.50 4.53 0.90 13.40 4.85 9.77 7.80 2.67 0.038 0.34 0.26
FIGF 0.25 0.07 0.28 0.07 0.60 0.51 0.29 0.10 1.09 0.76 0.46 0.34
HGF 0.12 0.02 0.37 0.12 0.31 0.14 0.99 0.40 3.05 0.26 1.17 0.45
LINGO1 0.15 0.11 0.77 0.30 1.42 0.50 0.40 0.14 5.18 0.06 0.54 0.61

CWM: Control white matter, Remyelinated: Remyelinated lesion, Demyelinated: Demyelinated inactive lesion, Active: Demyelinated active lesion, Re/CWM and De/Re ratio: remyelinated vs. control white matter and vs. demyelinated inactive lesions, respectively; p value were calculated by 2-sided U tests, unadjusted for multiple testing. p-values < 0.05 are printed in bold. 0.00: Values were below our detection limit, which was 0.01% GAPDH. Specimens analyzed: 6 normal white matter specimens from 4 subjects, 6 demyelinated inactive lesions from 4 subjects, 4 demyelinated active lesions from 3 subjects, and 4 remyelinated lesions from 3 subjects were dissected and used for qPCR analysis. The mean expression values are given as % GAPDH; SEM denotes standard error of the mean. *Ratios may be imprecise since at least one value was below or close to the detection limit.